WTW (NASDAQ: WTW) (the “Company”), a leading global advisory,
broking and solutions company, today announced financial results
for the third quarter ended September 30, 2023.
“Our strong revenue growth in the third quarter reflects the
value of our global model and the increasing impact of our ongoing
investments in talent and technology,” said Carl Hess, WTW’s chief
executive officer. “We continued to execute against our strategy
and posted solid margins through growth, simplification, and
transformation, as well as greater cost discipline. Looking ahead,
the continued strong demand for our differentiated services, the
traction of our transformation program and expense control
initiatives and the resilience of our business give us confidence
in our ability to deliver on our commitments for the year and to
drive profitable growth.”
Consolidated
Results
As reported, USD millions, except %
Key Metrics |
Q3-23 |
Q3-22 |
Y/Y Change |
Revenue1 |
$2,166 |
$1,953 |
Reported 11% | CC 9% | Organic 9% |
Income from Operations |
$159 |
$154 |
3% |
Operating Margin % |
7.3% |
7.9% |
(60) bps |
Adjusted Operating Income |
$351 |
$284 |
24% |
Adjusted Operating Margin % |
16.2% |
14.5% |
170 bps |
Net Income |
$139 |
$192 |
(28)% |
Adjusted Net Income |
$236 |
$243 |
(3)% |
Diluted EPS |
$1.29 |
$1.72 |
(25)% |
Adjusted Diluted EPS |
$2.24 |
$2.20 |
2% |
1 |
The revenue amounts included in
this release are presented on a U.S. GAAP basis except where stated
otherwise. This excludes reinsurance revenue which is reported in
discontinued operations. The segment discussion is on an organic
basis. |
Revenue was $2.17 billion for the third quarter of 2023, an
increase of 11% as compared to $1.95 billion for the same period in
the prior year. Excluding the impact of foreign currency, revenue
increased 9%. On an organic basis, revenue increased 9%. See
Supplemental Segment Information on page 8 for additional detail on
book-of-business settlements and interest income included in
revenue.
Net Income for the third quarter of 2023 was $139 million, a
decrease of 28% compared to Net Income of $192 million in the
prior-year third quarter. Adjusted EBITDA for the third quarter was
$436 million, or 20.1% of revenue, an increase of 7%, compared to
Adjusted EBITDA of $408 million, or 20.9% of revenue, in the
prior-year third quarter. The U.S. GAAP tax rate for the third
quarter was 15.5%, and the adjusted income tax rate for the third
quarter used in calculating adjusted diluted earnings per share was
24.3%.
Cash Flow and Capital
Allocation
Cash flows from operating activities were $823 million for the
nine months ended September 30, 2023, compared to $437 million for
the prior year. Free cash flow for the nine months ended September
30, 2023 and 2022 was $707 million and $337 million, respectively,
an improvement of $370 million. During the quarter ended September
30, 2023, the Company repurchased $350 million of WTW shares.
Quarterly Business
Highlights
- Realized $23 million of incremental annualized Transformation
program savings, bringing the total to $300 million in cumulative
savings since the program's inception. Refer to the Supplemental
Slides for additional detail.
- Repurchased 1,681,385 of our shares for $350 million.
- Announced the launch of Verita, a new managing general
underwriter focused on select industry verticals, including real
estate, hospitality and leisure, financial institutions and
professional services, to further advance our specialization
strategy in Risk & Broking.
Third Quarter 2023 Segment
Highlights
Health, Wealth & Career
As reported, USD millions, except %
Health, Wealth & Career |
Q3-23 |
Q3-22 |
Y/Y Change |
Total Revenue |
$1,282 |
$1,162 |
Reported 10% | CC 8% | Organic 9% |
Operating Income |
$305 |
$236 |
29% |
Operating Margin % |
23.8% |
20.3% |
350 bps |
The HWC segment had revenue of $1.28 billion in the third
quarter, an increase of 10% (8% increase constant currency and 9%
organic) from $1.16 billion in the prior year. Organic growth was
led by Benefits Delivery & Outsourcing, driven by new clients
and increased compliance and other project activity in Outsourcing
and growth from higher volumes and placements of Life and Medicare
Advantage in Individual Marketplace. Our Wealth businesses
generated organic revenue growth from higher levels of Retirement
work in North America and Europe, along with new client
acquisitions and higher fees in Investments. Organic revenue growth
in Health was driven by the continued expansion of our Global
Benefits Management client portfolio, new local clients, expanding
consulting work for existing clients and increased brokerage
income. Career had organic revenue growth from increased
compensation survey sales, executive compensation and other
reward-based advisory services, including pay transparency work and
change communication services.
Operating margins in the HWC segment increased 350 basis points
from the prior-year third quarter to 23.8%, primarily from
Transformation savings and higher operating leverage, with revenue
outpacing expense growth, and some timing between quarters.
Risk & Broking
As reported, USD millions, except %
Risk & Broking |
Q3-23 |
Q3-22 |
Y/Y Change |
Total Revenue |
$855 |
$765 |
Reported 12% | CC 10% | Organic 10% |
Operating Income |
$134 |
$105 |
28% |
Operating Margin % |
15.7% |
13.7% |
200 bps |
The R&B segment had revenue of $855 million in the third
quarter, an increase of 12% (10% increase constant currency and
organic) from $765 million in the prior year. Corporate Risk &
Broking generated solid organic revenue growth driven by strong new
business, improved client retention and rate increases. Insurance
Consulting and Technology had organic revenue growth from software
sales and increased project revenue.
Operating margins in the R&B segment increased 200 basis
points from the prior-year third quarter to 15.7%, due to
Transformation savings, expense management and higher operating
leverage driven by strong organic revenue growth and investments in
talent who are continuing to ramp up in their revenue
production.
Outlook
Based on current and anticipated market conditions, the
Company's full-year targets for 2023 are as follows:
- Expect to deliver mid-single digit organic revenue growth
- Expect to deliver adjusted operating margin expansion for the
full year 2023
- Expect to deliver approximately $160 million of incremental
run-rate savings from the Transformation program in 2023
- Expect approximately $112 million in non-cash pension income
for the full year 2023
- Expect a foreign currency headwind on adjusted earnings per
share of approximately $0.07 for the full year 2023 at today’s
rates, up from $0.05 previously
- Expect approximately 12% free cash flow margin for the full
year 2023. See Supplemental Materials for further information on
near-term and long-term free cash flow guidance.
Outlook includes Non-GAAP financial measures. We do not
reconcile forward-looking Non-GAAP measures for reasons explained
below.
Conference Call
The Company will host a live webcast and conference call to
discuss the financial results for the third quarter 2023. It will
be held on Thursday, October 26, 2023, beginning at 9:00 a.m.
Eastern Time. A live broadcast of the conference call will be
available on WTW’s website here. The conference call will include a
question-and-answer session. To participate in the
question-and-answer session, please register here. An online replay
will be available at www.wtwco.com shortly after the call
concludes.
About WTW
At WTW (NASDAQ: WTW), we provide data-driven, insight-led
solutions in the areas of people, risk and capital. Leveraging the
global view and local expertise of our colleagues serving 140
countries and markets, we help organizations sharpen their
strategy, enhance organizational resilience, motivate their
workforce and maximize performance. Working shoulder to shoulder
with our clients, we uncover opportunities for sustainable
success—and provide perspective that moves you. Learn more at
www.wtwco.com.
WTW Non-GAAP Measures
In order to assist readers of our consolidated financial
statements in understanding the core operating results that WTW’s
management uses to evaluate the business and for financial
planning, we present the following non-GAAP measures: (1) Constant
Currency Change, (2) Organic Change, (3) Adjusted Operating
Income/Margin, (4) Adjusted EBITDA/Margin, (5) Adjusted Net Income,
(6) Adjusted Diluted Earnings Per Share, (7) Adjusted Income Before
Taxes, (8) Adjusted Income Taxes/Tax Rate, (9) Free Cash Flow and
(10) Free Cash Flow Margin.
We believe that those measures are relevant and provide
pertinent information widely used by analysts, investors and other
interested parties in our industry to provide a baseline for
evaluating and comparing our operating performance, and in the case
of free cash flow, our liquidity results.
Within the measures referred to as ‘adjusted’, we adjust for
significant items which will not be settled in cash, or which we
believe to be items that are not core to our current or future
operations. Some of these items may not be applicable for the
current quarter, however they may be part of our full-year results.
Additionally, we have historically adjusted for certain items which
are not described below, but for which we may adjust in a future
period when applicable. Items applicable to the quarter or full
year results, or the comparable periods, include the following:
- Income and loss from discontinued operations, net of tax –
Adjustment to remove the after-tax income or loss from discontinued
operations and the after-tax gain attributable to the divestiture
of our Willis Re business.
- Restructuring costs and transaction and transformation –
Management believes it is appropriate to adjust for restructuring
costs and transaction and transformation when they relate to a
specific significant program with a defined set of activities and
costs that are not expected to continue beyond a defined period of
time, or significant acquisition-related transaction expenses. We
believe the adjustment is necessary to present how the Company is
performing, both now and in the future when the incurrence of these
costs will have concluded.
- Impairment – Adjustment to remove the impairment related to the
net assets of our Russian business that are held outside of our
Russian entities.
- Gains and losses on disposals of operations – Adjustment to
remove the gains or losses resulting from disposed operations that
have not been classified as discontinued operations.
- Tax effect of the Coronavirus Aid, Relief, and Economic
Security (‘CARES’) Act – Relates to the incremental tax expense or
benefit, primarily from the Base Erosion and Anti-Abuse Tax
(‘BEAT’), generated from electing or changing elections of certain
income tax provisions available under the CARES Act.
- Tax effect of internal reorganizations – Relates to the U.S.
income tax expense resulting from the completion of internal
reorganizations of the ownership of certain businesses that reduced
the investments held by our U.S.-controlled subsidiaries.
We evaluate our revenue on an as reported (U.S. GAAP), constant
currency and organic basis. We believe presenting constant currency
and organic information provides valuable supplemental information
regarding our comparable results, consistent with how we evaluate
our performance internally.
We consider Constant Currency Change, Organic Change, Adjusted
Operating Income/Margin, Adjusted EBITDA/Margin, Adjusted Net
Income, Adjusted Diluted Earnings Per Share, Adjusted Income Before
Taxes, Adjusted Income Taxes/Tax Rate and Free Cash Flow to be
important financial measures, which are used to internally evaluate
and assess our core operations and to benchmark our operating and
liquidity results against our competitors. These non-GAAP measures
are important in illustrating what our comparable operating and
liquidity results would have been had we not incurred
transaction-related and non-recurring items. Our non-GAAP measures
and their accompanying definitions are presented as follows:
Constant Currency Change – Represents the year-over-year change
in revenue excluding the impact of foreign currency fluctuations.
To calculate this impact, the prior year local currency results are
first translated using the current year monthly average exchange
rates. The change is calculated by comparing the prior year
revenue, translated at the current year monthly average exchange
rates, to the current year as reported revenue, for the same
period. We believe constant currency measures provide useful
information to investors because they provide transparency to
performance by excluding the effects that foreign currency exchange
rate fluctuations have on period-over-period comparability given
volatility in foreign currency exchange markets.
Organic Change – Excludes the impact of fluctuations in foreign
currency exchange rates, as described above and the
period-over-period impact of acquisitions and divestitures on
current-year revenue. We believe that excluding transaction-related
items from our U.S. GAAP financial measures provides useful
supplemental information to our investors, and it is important in
illustrating what our core operating results would have been had we
not included these transaction-related items, since the nature,
size and number of these transaction-related items can vary from
period to period.
Adjusted Operating Income/Margin – Income from operations
adjusted for amortization, restructuring costs, transaction and
transformation and non-recurring items that, in management’s
judgment, significantly affect the period-over-period assessment of
operating results. Adjusted operating income margin is calculated
by dividing adjusted operating income by revenue. We consider
adjusted operating income/margin to be important financial
measures, which are used internally to evaluate and assess our core
operations and to benchmark our operating results against our
competitors.
Adjusted EBITDA/Margin – Net Income adjusted for loss/(income)
from discontinued operations, net of tax, provision for income
taxes, interest expense, depreciation and amortization,
restructuring costs, transaction and transformation, gains and
losses on disposals of operations and non-recurring items that, in
management’s judgment, significantly affect the period-over-period
assessment of operating results. Adjusted EBITDA Margin is
calculated by dividing adjusted EBITDA by revenue. We consider
adjusted EBITDA/margin to be important financial measures, which
are used internally to evaluate and assess our core operations, to
benchmark our operating results against our competitors and to
evaluate and measure our performance-based compensation plans.
Adjusted Net Income – Net Income Attributable to WTW adjusted
for loss/(income) from discontinued operations, net of tax,
amortization, restructuring costs, transaction and transformation,
gains and losses on disposals of operations and non-recurring items
that, in management’s judgment, significantly affect the
period-over-period assessment of operating results and the related
tax effect of those adjustments and the tax effects of internal
reorganizations. This measure is used solely for the purpose of
calculating adjusted diluted earnings per share.
Adjusted Diluted Earnings Per Share – Adjusted Net Income
divided by the weighted-average number of ordinary shares, diluted.
Adjusted diluted earnings per share is used to internally evaluate
and assess our core operations and to benchmark our operating
results against our competitors.
Adjusted Income Before Taxes – Income from operations before
income taxes adjusted for amortization, restructuring costs,
transaction and transformation, gains and losses on disposals of
operations and non-recurring items that, in management’s judgment,
significantly affect the period-over-period assessment of operating
results. Adjusted income before taxes is used solely for the
purpose of calculating the adjusted income tax rate.
Adjusted Income Taxes/Tax Rate – Provision for income taxes
adjusted for taxes on certain items of amortization, restructuring
costs, transaction and transformation, gains and losses on
disposals of operations, the tax effects of internal
reorganizations, and non-recurring items that, in management’s
judgment, significantly affect the period-over-period assessment of
operating results, divided by adjusted income before taxes.
Adjusted income taxes is used solely for the purpose of calculating
the adjusted income tax rate. Management believes that the adjusted
income tax rate presents a rate that is more closely aligned to the
rate that we would incur if not for the reduction of pre-tax income
for the adjusted items and the tax effects of internal
reorganizations, which are not core to our current and future
operations.
Free Cash Flow – Cash flows from operating
activities less cash used to purchase fixed assets and software for
internal use. Free Cash Flow is a liquidity measure and is not
meant to represent residual cash flow available for discretionary
expenditures. Management believes that free cash flow presents the
core operating performance and cash-generating capabilities of our
business operations.
Free Cash Flow Margin – Free Cash Flow as a
percentage of revenue, which represents how much of revenue would
be realized on a cash basis. Revenue used in the calculation of
Free Cash Flow Margin includes revenue from discontinued operations
attributable to the divestiture of our Willis Re business during
2021. We consider this measure to be a meaningful metric for
tracking cash conversion on a year-over-year basis due to the
non-cash nature of our pension income, which is included in our
GAAP and Non-GAAP earnings metrics presented herein.
These non-GAAP measures are not defined in the
same manner by all companies and may not be comparable to other
similarly titled measures of other companies. Non-GAAP measures
should be considered in addition to, and not as a substitute for,
the information contained within our condensed consolidated
financial statements.
Reconciliations of these measures are included
in the accompanying tables with the following exception:
The Company does not reconcile its forward-looking non-GAAP
financial measures to the corresponding U.S. GAAP measures, due to
variability and difficulty in making accurate forecasts and
projections and/or certain information not being ascertainable or
accessible; and because not all of the information, such as foreign
currency impacts necessary for a quantitative reconciliation of
these forward-looking non-GAAP financial measures to the most
directly comparable U.S. GAAP financial measure, is available to
the Company without unreasonable efforts. For the same reasons, the
Company is unable to address the probable significance of the
unavailable information. The Company provides non-GAAP financial
measures that it believes will be achieved, however it cannot
accurately predict all of the components of the adjusted
calculations and the U.S. GAAP measures may be materially different
than the non-GAAP measures.
WTW Forward-Looking Statements
This document contains ‘forward-looking statements’ within the
meaning of Section 27A of the Securities Act of 1933, and Section
21E of the Securities Exchange Act of 1934, which are intended to
be covered by the safe harbors created by those laws. These
forward-looking statements include information about possible or
assumed future results of our operations. All statements, other
than statements of historical facts, that address activities,
events, or developments that we expect or anticipate may occur in
the future, including such things as our outlook, the potential
impact of natural or man-made disasters like health pandemics and
other world health crises on; future capital expenditures; ongoing
working capital efforts; future share repurchases; financial
results (including our revenue, costs, or margins) and the impact
of changes to tax laws on our financial results; existing and
evolving business strategies and acquisitions and dispositions,
including our completed sale of Willis Re to Arthur J. Gallagher
& Co. (‘Gallagher’) and transitional arrangements related
thereto; demand for our services and competitive strengths;
strategic goals; the benefits of new initiatives; growth of our
business and operations; our ability to successfully manage ongoing
leadership, organizational and technology changes, including
investments in improving systems and processes; our ability to
implement and realize anticipated benefits of any cost-savings
initiatives including the multi-year operational Transformation
program; and plans and references to future successes, including
our future financial and operating results, short-term and
long-term financial goals, plans, objectives, expectations and
intentions are forward-looking statements including with respect to
free cash flow generation, adjusted net revenue, adjusted operating
margin, and adjusted earnings per share. Also, when we use words
such as ‘may’, ‘will’, ‘would’, ‘anticipate’, ‘believe’,
‘estimate’, ‘expect’, ‘intend’, ‘plan’, ‘continues’, ‘seek’,
‘target’, ‘goal’, ‘focus’, ‘probably’, or similar expressions, we
are making forward-looking statements. Such statements are based
upon the current beliefs and expectations of the Company’s
management and are subject to significant risks and uncertainties.
Actual results may differ from those set forth in the
forward-looking statements. All forward-looking disclosure is
speculative by its nature.
There are important risks, uncertainties, events and factors
that could cause our actual results or performance to differ
materially from those in the forward-looking statements contained
in this document, including the following: our ability to
successfully establish, execute and achieve our global business
strategy as it evolves; our ability to fully realize anticipated
benefits of our growth strategy; our ability to achieve our
short-term and long-term financial goals, such as with respect to
our cash flow generation, and the timing with respect to such
achievement; the risks related to changes in general economic
(including a possible recession), business and political
conditions, including changes in the financial markets, inflation,
credit availability, increased interest rates and trade policies;
the risks to our short-term and long-term financial goals from any
of the risks or uncertainties set forth herein; the risks to our
business, financial condition, results of operations, and long-term
goals that may be materially adversely affected by any negative
impact on the global economy and capital markets resulting from or
relating to inflation, the military conflict between Russia and
Ukraine, evolving events in Israel and Gaza or any other
geopolitical tensions and the withdrawal from our high margin
businesses in Russia and our ability to achieve cost-mitigation
measures; our ability to successfully hedge against fluctuations in
foreign currency rates; the risks relating to the adverse impacts
of natural or man-made disasters like health pandemics and other
world health crises, such as the COVID-19 pandemic, including
supply chain, workforce availability, vaccination rates, and other
impacts on the people and businesses in jurisdictions where we do
business, on the demand for our products and services, our cash
flows and our business operations; material interruptions to or
loss of our information processing capabilities, or failure to
effectively maintain and upgrade our information technology
resources and systems and related risks of cybersecurity breaches
or incidents; our ability to comply with complex and evolving
regulations related to data privacy, cybersecurity and artificial
intelligence; the risks relating to the transitional arrangements
in effect subsequent to our now-completed sale of Willis Re to
Gallagher; significant competition that we face and the potential
for loss of market share and/or profitability; the impact of
seasonality and differences in timing of renewals and non-recurring
revenue increases from disposals and book-of-business sales; the
failure to protect client data or breaches of information systems
or insufficient safeguards against cybersecurity breaches or
incidents; the risk of increased liability or new legal claims
arising from our new and existing products and services, and
expectations, intentions and outcomes relating to outstanding
litigation; the risk of substantial negative outcomes on existing
litigation or investigation matters; changes in the regulatory
environment in which we operate, including, among other risks, the
impacts of pending competition law and regulatory investigations;
various claims, government inquiries or investigations or the
potential for regulatory action; our ability to make divestitures
or acquisitions, including our ability to integrate or manage such
acquired businesses, as well as identify and successfully execute
on opportunities for strategic collaboration; our ability to
integrate direct-to-consumer sales and marketing solutions with our
existing offerings and solutions; our ability to successfully
manage ongoing organizational changes, including investments in
improving systems and processes; disasters or business continuity
problems; the ongoing impact of Brexit on our business and
operations, including as a result of updated regulatory guidance,
such as that issued by the European Insurance and Occupational
Pensions Authority on February 3, 2023, ongoing efforts and
resources allocated to the post-Brexit evolution of regulations and
laws and the need to relocate talent or roles or both between or
within the E.U. and the U.K., or otherwise; our ability to
successfully enhance our billing, collection and other working
capital efforts, and thereby increase our free cash flow; our
ability to properly identify and manage conflicts of interest;
reputational damage, including from association with third parties;
reliance on third-party service providers and suppliers; risks
relating to changes in our management structures and in senior
leadership; the loss of key employees or a large number of
employees and rehiring rates; our ability to maintain our corporate
culture; doing business internationally, including the impact of
foreign currency exchange rates; compliance with extensive
government regulation; the risk of sanctions imposed by
governments, or changes to associated sanction regulations (such as
sanctions imposed on Russia) and related counter-sanctions; our
ability to effectively apply technology, data and analytics changes
for internal operations, maintaining industry standards and meeting
client preferences; changes and developments in the insurance
industry or the U.S. healthcare system, including those related to
Medicare and any legislative actions from the current U.S.
Congress, and any other changes and developments in legal,
economic, business or operational conditions impacting our Medicare
benefits businesses such as TRANZACT; the inability to protect our
intellectual property rights, or the potential infringement upon
the intellectual property rights of others; fluctuations in our
pension assets and liabilities and related changes in pension
income, including as a result of, related to, or derived from
movements in the interest rate environment, investment returns,
inflation, or changes in other assumptions that are used to
estimate our benefit obligations and its effect on adjusted
earnings per share; our capital structure, including indebtedness
amounts, the limitations imposed by the covenants in the documents
governing such indebtedness and the maintenance of the financial
and disclosure controls and procedures of each; our ability to
obtain financing on favorable terms or at all; adverse changes in
our credit ratings; the impact of recent or potential changes to
U.S. or foreign laws, and the enactment of additional, or the
revision of existing, state, federal, and/or foreign laws and
regulations, recent judicial decisions and development of case law,
other regulations and any policy changes and legislative actions,
including those that impact our effective tax rate; U.S. federal
income tax consequences to U.S. persons owning at least 10% of our
shares; changes in accounting principles, estimates or assumptions;
risks relating to or arising from environmental, social and
governance (‘ESG’) practices; fluctuation in revenue against our
relatively fixed or higher than expected expenses; the laws of
Ireland being different from the laws of the U.S. and potentially
affording less protections to the holders of our securities; and
our holding company structure potentially preventing us from being
able to receive dividends or other distributions in needed amounts
from our subsidiaries. The foregoing list of factors is not
exhaustive and new factors may emerge from time to time that could
also affect actual performance and results. For more information,
please see Part I, Item 1A in our Annual Report on Form 10-K, and
our subsequent filings with the SEC. Copies are available online at
www.sec.gov or www.wtwco.com.
Although we believe that the assumptions underlying our
forward-looking statements are reasonable, any of these
assumptions, and therefore also the forward-looking statements
based on these assumptions, could themselves prove to be
inaccurate. Given the significant uncertainties inherent in the
forward-looking statements included in this document, our inclusion
of this information is not a representation or guarantee by us that
our objectives and plans will be achieved.
Our forward-looking statements speak only as of the date made,
and we will not update these forward-looking statements unless the
securities laws require us to do so. With regard to these risks,
uncertainties and assumptions, the forward-looking events discussed
in this document may not occur, and we caution you against unduly
relying on these forward-looking statements.
Contact
INVESTORS
Claudia De La Hoz |
Claudia.Delahoz@wtwco.com
WTWSupplemental Segment Information(In millions of
U.S. dollars)(Unaudited) |
REVENUE |
|
|
|
|
|
|
|
|
|
Components of Revenue Change(i) |
|
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
Less: |
|
|
|
|
Three Months Ended September 30, |
|
|
As Reported |
|
Currency |
|
Constant Currency |
|
Acquisitions/ |
|
Organic |
|
|
2023 |
|
|
2022 |
|
|
% Change |
|
Impact |
|
Change |
|
Divestitures |
|
Change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health, Wealth & Career |
|
$ |
1,282 |
|
|
$ |
1,162 |
|
|
10% |
|
2% |
|
8% |
|
0% |
|
9% |
Risk & Broking |
|
|
855 |
|
|
|
765 |
|
|
12% |
|
2% |
|
10% |
|
0% |
|
10% |
Segment
Revenue |
|
|
2,137 |
|
|
|
1,927 |
|
|
11% |
|
2% |
|
9% |
|
0% |
|
9% |
Reimbursable expenses and
other |
|
|
29 |
|
|
|
26 |
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
$ |
2,166 |
|
|
$ |
1,953 |
|
|
11% |
|
2% |
|
9% |
|
0% |
|
9% |
|
|
|
|
|
|
|
|
|
|
Components of Revenue Change(i) |
|
|
|
|
|
|
|
Less: |
|
|
|
Less: |
|
|
|
|
Nine Months Ended September 30, |
|
|
As Reported |
|
Currency |
|
Constant Currency |
|
Acquisitions/ |
|
Organic |
|
|
2023 |
|
|
2022 |
|
|
% Change |
|
Impact |
|
Change |
|
Divestitures |
|
Change |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health, Wealth & Career |
|
$ |
3,784 |
|
|
$ |
3,565 |
|
|
6% |
|
0% |
|
7% |
|
0% |
|
7% |
Risk & Broking |
|
|
2,659 |
|
|
|
2,508 |
|
|
6% |
|
(1)% |
|
7% |
|
(2)% |
|
9% |
Segment
Revenue |
|
|
6,443 |
|
|
|
6,073 |
|
|
6% |
|
(1)% |
|
7% |
|
(1)% |
|
8% |
Reimbursable expenses and
other |
|
|
126 |
|
|
|
71 |
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
$ |
6,569 |
|
|
$ |
6,144 |
|
|
7% |
|
(1)% |
|
8% |
|
(1)% |
|
8% |
(i) Components of revenue change may not add due to
rounding.
BOOK-OF-BUSINESS SETTLEMENTS AND INTEREST
INCOME
|
|
Three Months Ended September 30, |
|
|
|
HWC |
|
|
R&B |
|
|
Corporate |
|
|
Total |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Book-of-business settlements |
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
1 |
|
|
$ |
11 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
12 |
|
Interest income |
|
|
7 |
|
|
|
2 |
|
|
|
25 |
|
|
|
6 |
|
|
|
7 |
|
|
|
9 |
|
|
|
39 |
|
|
|
17 |
|
Total interest and other
income |
|
$ |
7 |
|
|
$ |
3 |
|
|
$ |
26 |
|
|
$ |
17 |
|
|
$ |
7 |
|
|
$ |
9 |
|
|
$ |
40 |
|
|
$ |
29 |
|
|
|
Nine Months Ended September 30, |
|
|
|
HWC |
|
|
R&B |
|
|
Corporate |
|
|
Total |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Book-of-business settlements |
|
$ |
— |
|
|
$ |
19 |
|
|
$ |
11 |
|
|
$ |
41 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
11 |
|
|
$ |
60 |
|
Interest income |
|
|
18 |
|
|
|
4 |
|
|
|
52 |
|
|
|
15 |
|
|
|
36 |
|
|
|
9 |
|
|
|
106 |
|
|
|
28 |
|
Total interest and other
income |
|
$ |
18 |
|
|
$ |
23 |
|
|
$ |
63 |
|
|
$ |
56 |
|
|
$ |
36 |
|
|
$ |
9 |
|
|
$ |
117 |
|
|
$ |
88 |
|
SEGMENT OPERATING INCOME (i)
|
|
Three Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Health, Wealth & Career |
|
$ |
305 |
|
|
$ |
236 |
|
Risk & Broking |
|
|
134 |
|
|
|
105 |
|
Segment Operating
Income |
|
$ |
439 |
|
|
$ |
341 |
|
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Health, Wealth & Career |
|
$ |
836 |
|
|
$ |
710 |
|
Risk & Broking |
|
|
459 |
|
|
|
465 |
|
Segment Operating
Income |
|
$ |
1,295 |
|
|
$ |
1,175 |
|
(i) Segment operating income excludes certain costs, including
amortization of intangibles, restructuring costs, transaction and
transformation expenses, certain litigation provisions, and to the
extent that the actual expense based upon which allocations are
made differs from the forecast/budget amount, a reconciling item
will be created between internally-allocated expenses and the
actual expenses reported for U.S. GAAP purposes.
SEGMENT OPERATING MARGINS
|
|
Three Months EndedSeptember 30, |
|
|
2023 |
|
2022 |
Health, Wealth &
Career |
|
23.8% |
|
20.3% |
Risk & Broking |
|
15.7% |
|
13.7% |
|
|
Nine Months EndedSeptember 30, |
|
|
2023 |
|
2022 |
Health, Wealth &
Career |
|
22.1% |
|
19.9% |
Risk & Broking |
|
17.3% |
|
18.5% |
RECONCILIATIONS OF SEGMENT OPERATING INCOME TO INCOME
FROM OPERATIONS BEFORE INCOME TAXES
|
|
Three Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Segment Operating Income |
|
$ |
439 |
|
|
$ |
341 |
|
Amortization |
|
|
(62 |
) |
|
|
(71 |
) |
Restructuring costs |
|
|
(17 |
) |
|
|
(9 |
) |
Transaction and
transformation(i) |
|
|
(113 |
) |
|
|
(50 |
) |
Unallocated, net(ii) |
|
|
(88 |
) |
|
|
(57 |
) |
Income from Operations |
|
|
159 |
|
|
|
154 |
|
Interest expense |
|
|
(61 |
) |
|
|
(54 |
) |
Other income, net |
|
|
66 |
|
|
|
85 |
|
Income from continuing
operations before income taxes |
|
$ |
164 |
|
|
$ |
185 |
|
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Segment Operating Income |
|
$ |
1,295 |
|
|
$ |
1,175 |
|
Impairment(iii) |
|
|
— |
|
|
|
(81 |
) |
Amortization |
|
|
(203 |
) |
|
|
(239 |
) |
Restructuring costs |
|
|
(30 |
) |
|
|
(71 |
) |
Transaction and
transformation(i) |
|
|
(265 |
) |
|
|
(108 |
) |
Unallocated, net(ii) |
|
|
(211 |
) |
|
|
(206 |
) |
Income from Operations |
|
|
586 |
|
|
|
470 |
|
Interest expense |
|
|
(172 |
) |
|
|
(154 |
) |
Other income, net |
|
|
126 |
|
|
|
205 |
|
Income from operations before
income taxes |
|
$ |
540 |
|
|
$ |
521 |
|
(i) In 2023 and 2022, in addition to legal fees and other
transaction costs, includes primarily consulting fees and
compensation costs related to the Transformation program. (ii)
Includes certain costs, primarily related to corporate functions
which are not directly related to the segments, and certain
differences between budgeted expenses determined at the beginning
of the year and actual expenses that we report for U.S. GAAP
purposes. (iii) Represents the impairment related to the net
assets of our Russian business that are held outside of our Russian
entities.
WTWReconciliations of
Non-GAAP Measures (In millions of U.S. dollars, except per
share data)(Unaudited)
RECONCILIATIONS OF NET INCOME ATTRIBUTABLE TO WTW TO
ADJUSTED DILUTED EARNINGS PER SHARE
|
|
Three Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Net Income attributable to WTW |
|
$ |
136 |
|
|
$ |
190 |
|
Adjusted for certain
items: |
|
|
|
|
|
|
Income from discontinued operations, net of tax |
|
|
— |
|
|
|
(8 |
) |
Amortization |
|
|
62 |
|
|
|
71 |
|
Restructuring costs |
|
|
17 |
|
|
|
9 |
|
Transaction and transformation |
|
|
113 |
|
|
|
50 |
|
Gain on disposal of operations |
|
|
(41 |
) |
|
|
(21 |
) |
Tax effect on certain items listed above(i) |
|
|
(51 |
) |
|
|
(24 |
) |
Tax effect of the CARES Act |
|
|
— |
|
|
|
(24 |
) |
Adjusted Net
Income |
|
$ |
236 |
|
|
$ |
243 |
|
|
|
|
|
|
|
|
Weighted-average ordinary
shares, diluted |
|
|
105 |
|
|
|
111 |
|
|
|
|
|
|
|
|
Diluted Earnings Per
Share |
|
$ |
1.29 |
|
|
$ |
1.72 |
|
Adjusted for certain
items:(ii) |
|
|
|
|
|
|
Income from discontinued operations, net of tax |
|
|
— |
|
|
|
(0.07 |
) |
Amortization |
|
|
0.59 |
|
|
|
0.64 |
|
Restructuring costs |
|
|
0.16 |
|
|
|
0.08 |
|
Transaction and transformation |
|
|
1.07 |
|
|
|
0.45 |
|
Gain on disposal of operations |
|
|
(0.39 |
) |
|
|
(0.19 |
) |
Tax effect on certain items listed above(i) |
|
|
(0.48 |
) |
|
|
(0.22 |
) |
Tax effect of the CARES Act |
|
|
— |
|
|
|
(0.22 |
) |
Adjusted Diluted
Earnings Per Share(ii) |
|
$ |
2.24 |
|
|
$ |
2.20 |
|
(i) The tax effect was calculated using an effective tax
rate for each item.(ii) Per share values and totals may differ due
to rounding.
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
|
|
|
|
|
|
Net Income attributable to WTW |
|
$ |
433 |
|
|
$ |
421 |
|
Adjusted for certain
items: |
|
|
|
|
|
|
Loss from discontinued operations, net of tax |
|
|
— |
|
|
|
27 |
|
Impairment |
|
|
— |
|
|
|
81 |
|
Amortization |
|
|
203 |
|
|
|
239 |
|
Restructuring costs |
|
|
30 |
|
|
|
71 |
|
Transaction and transformation |
|
|
265 |
|
|
|
108 |
|
(Gain)/loss on disposal of operations |
|
|
(44 |
) |
|
|
11 |
|
Tax effect on certain items listed above(i) |
|
|
(128 |
) |
|
|
(116 |
) |
Tax effect of the CARES Act |
|
|
— |
|
|
|
(24 |
) |
Tax effects of internal reorganizations |
|
|
2 |
|
|
|
— |
|
Adjusted Net
Income |
|
$ |
761 |
|
|
$ |
818 |
|
|
|
|
|
|
|
|
Weighted-average ordinary
shares, diluted |
|
|
107 |
|
|
|
114 |
|
|
|
|
|
|
|
|
Diluted Earnings Per
Share |
|
$ |
4.06 |
|
|
$ |
3.71 |
|
Adjusted for certain
items:(ii) |
|
|
|
|
|
|
Loss from discontinued operations, net of tax |
|
|
— |
|
|
|
0.24 |
|
Impairment |
|
|
— |
|
|
|
0.71 |
|
Amortization |
|
|
1.90 |
|
|
|
2.10 |
|
Restructuring costs |
|
|
0.28 |
|
|
|
0.62 |
|
Transaction and transformation |
|
|
2.48 |
|
|
|
0.95 |
|
(Gain)/loss on disposal of operations |
|
|
(0.41 |
) |
|
|
0.10 |
|
Tax effect on certain items listed above(i) |
|
|
(1.20 |
) |
|
|
(1.02 |
) |
Tax effect of the CARES Act |
|
|
— |
|
|
|
(0.21 |
) |
Tax effects of internal reorganizations |
|
|
0.02 |
|
|
|
— |
|
Adjusted Diluted
Earnings Per Share(ii) |
|
$ |
7.13 |
|
|
$ |
7.20 |
|
(i) The tax effect was calculated using an effective tax
rate for each item.(ii) Per share values and totals may differ due
to rounding.
RECONCILIATIONS OF NET INCOME TO ADJUSTED
EBITDA
|
|
Three Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
$ |
139 |
|
|
6.4 |
% |
$ |
192 |
|
|
|
9.8 |
% |
Income from discontinued operations, net of tax |
|
|
— |
|
|
|
|
(8 |
) |
|
|
|
Provision for income taxes |
|
|
25 |
|
|
|
|
1 |
|
|
|
|
Interest expense |
|
|
61 |
|
|
|
|
54 |
|
|
|
|
Depreciation |
|
|
60 |
|
|
|
|
60 |
|
|
|
|
Amortization |
|
|
62 |
|
|
|
|
71 |
|
|
|
|
Restructuring costs |
|
|
17 |
|
|
|
|
9 |
|
|
|
|
Transaction and transformation |
|
|
113 |
|
|
|
|
50 |
|
|
|
|
Gain on disposal of operations |
|
|
(41 |
) |
|
|
|
(21 |
) |
|
|
|
Adjusted EBITDA and
Adjusted EBITDA Margin |
|
$ |
436 |
|
|
20.1 |
% |
$ |
408 |
|
|
|
20.9 |
% |
|
|
Nine Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income |
|
$ |
441 |
|
|
6.7 |
% |
$ |
431 |
|
|
|
7.0 |
% |
Loss from discontinued operations, net of tax |
|
|
— |
|
|
|
|
27 |
|
|
|
|
Provision for income taxes |
|
|
99 |
|
|
|
|
63 |
|
|
|
|
Interest expense |
|
|
172 |
|
|
|
|
154 |
|
|
|
|
Impairment |
|
|
— |
|
|
|
|
81 |
|
|
|
|
Depreciation |
|
|
184 |
|
|
|
|
191 |
|
|
|
|
Amortization |
|
|
203 |
|
|
|
|
239 |
|
|
|
|
Restructuring costs |
|
|
30 |
|
|
|
|
71 |
|
|
|
|
Transaction and transformation |
|
|
265 |
|
|
|
|
108 |
|
|
|
|
(Gain)/loss on disposal of operations |
|
|
(44 |
) |
|
|
|
11 |
|
|
|
|
Adjusted EBITDA and
Adjusted EBITDA Margin |
|
$ |
1,350 |
|
|
20.6 |
% |
$ |
1,376 |
|
|
|
22.4 |
% |
RECONCILIATIONS OF INCOME FROM OPERATIONS TO ADJUSTED
OPERATING INCOME
|
|
Three Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations and Operating margin |
|
$ |
159 |
|
|
7.3 |
% |
$ |
154 |
|
|
|
7.9 |
% |
Adjusted for certain
items: |
|
|
|
|
|
|
|
|
|
|
Amortization |
|
|
62 |
|
|
|
|
71 |
|
|
|
|
Restructuring costs |
|
|
17 |
|
|
|
|
9 |
|
|
|
|
Transaction and transformation |
|
|
113 |
|
|
|
|
50 |
|
|
|
|
Adjusted operating
income and Adjusted operating income margin |
|
$ |
351 |
|
|
16.2 |
% |
$ |
284 |
|
|
|
14.5 |
% |
|
|
Nine Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations and Operating margin |
|
$ |
586 |
|
|
8.9 |
% |
$ |
470 |
|
|
|
7.6 |
% |
Adjusted for certain
items: |
|
|
|
|
|
|
|
|
|
|
Impairment |
|
|
— |
|
|
|
|
81 |
|
|
|
|
Amortization |
|
|
203 |
|
|
|
|
239 |
|
|
|
|
Restructuring costs |
|
|
30 |
|
|
|
|
71 |
|
|
|
|
Transaction and
transformation |
|
|
265 |
|
|
|
|
108 |
|
|
|
|
Adjusted operating
income and Adjusted operating income margin |
|
$ |
1,084 |
|
|
16.5 |
% |
$ |
969 |
|
|
|
15.8 |
% |
RECONCILIATIONS OF GAAP INCOME TAXES/TAX RATE TO
ADJUSTED INCOME TAXES/TAX RATE
|
|
Three Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
2022 |
|
Income from continuing
operations before income taxes |
|
$ |
164 |
|
|
$ |
185 |
|
|
|
|
|
|
|
|
Adjusted for certain
items: |
|
|
|
|
|
|
Amortization |
|
|
62 |
|
|
|
71 |
|
Restructuring costs |
|
|
17 |
|
|
|
9 |
|
Transaction and transformation |
|
|
113 |
|
|
|
50 |
|
Gain on disposal of operations |
|
|
(41 |
) |
|
|
(21 |
) |
Adjusted income before
taxes |
|
$ |
315 |
|
|
$ |
294 |
|
|
|
|
|
|
|
|
Provision for income
taxes |
|
$ |
25 |
|
|
$ |
1 |
|
Tax effect on certain items listed above(i) |
|
|
51 |
|
|
|
24 |
|
Tax effect of the CARES Act |
|
|
— |
|
|
|
24 |
|
Adjusted income
taxes |
|
$ |
76 |
|
|
$ |
49 |
|
|
|
|
|
|
|
|
U.S. GAAP tax
rate |
|
|
15.5 |
% |
|
|
0.7 |
% |
Adjusted income tax
rate |
|
|
24.3 |
% |
|
|
16.8 |
% |
|
|
Nine Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
2022 |
|
Income from continuing
operations before income taxes |
|
$ |
540 |
|
|
$ |
521 |
|
|
|
|
|
|
|
|
Adjusted for certain
items: |
|
|
|
|
|
|
Impairment |
|
|
— |
|
|
|
81 |
|
Amortization |
|
|
203 |
|
|
|
239 |
|
Restructuring costs |
|
|
30 |
|
|
|
71 |
|
Transaction and transformation |
|
|
265 |
|
|
|
108 |
|
(Gain)/loss on disposal of operations |
|
|
(44 |
) |
|
|
11 |
|
Adjusted income before
taxes |
|
$ |
994 |
|
|
$ |
1,031 |
|
|
|
|
|
|
|
|
Provision for income
taxes |
|
$ |
99 |
|
|
$ |
63 |
|
Tax effect on certain items listed above(i) |
|
|
128 |
|
|
|
116 |
|
Tax effect of the CARES Act |
|
|
— |
|
|
|
24 |
|
Tax effect of internal reorganizations |
|
|
(2 |
) |
|
|
— |
|
Adjusted income
taxes |
|
$ |
225 |
|
|
$ |
203 |
|
|
|
|
|
|
|
|
U.S. GAAP tax
rate |
|
|
18.3 |
% |
|
|
12.1 |
% |
Adjusted income tax
rate |
|
|
22.6 |
% |
|
|
19.7 |
% |
(i) The tax effect was calculated using an effective tax rate
for each item.
RECONCILIATION OF CASH FLOWS FROM OPERATING ACTIVITIES
TO FREE CASH FLOW
|
|
Nine Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
2022 |
|
Cash flows from
operating activities |
|
$ |
823 |
|
|
$ |
437 |
|
Less: Additions to fixed
assets and software for internal use |
|
|
(116 |
) |
|
|
(100 |
) |
Free Cash
Flow |
|
$ |
707 |
|
|
$ |
337 |
|
WILLIS TOWERS WATSON PUBLIC LIMITED
COMPANYCondensed Consolidated Statements of
Income(In millions of U.S. dollars, except per share
data)(Unaudited) |
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Revenue |
|
$ |
2,166 |
|
|
$ |
1,953 |
|
|
$ |
6,569 |
|
|
$ |
6,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs of providing
services |
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and benefits |
|
|
1,359 |
|
|
|
1,225 |
|
|
|
4,019 |
|
|
|
3,802 |
|
Other operating expenses |
|
|
396 |
|
|
|
384 |
|
|
|
1,282 |
|
|
|
1,263 |
|
Depreciation |
|
|
60 |
|
|
|
60 |
|
|
|
184 |
|
|
|
191 |
|
Amortization |
|
|
62 |
|
|
|
71 |
|
|
|
203 |
|
|
|
239 |
|
Restructuring costs |
|
|
17 |
|
|
|
9 |
|
|
|
30 |
|
|
|
71 |
|
Transaction and transformation |
|
|
113 |
|
|
|
50 |
|
|
|
265 |
|
|
|
108 |
|
Total costs of providing
services |
|
|
2,007 |
|
|
|
1,799 |
|
|
|
5,983 |
|
|
|
5,674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from operations |
|
|
159 |
|
|
|
154 |
|
|
|
586 |
|
|
|
470 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(61 |
) |
|
|
(54 |
) |
|
|
(172 |
) |
|
|
(154 |
) |
Other income, net |
|
|
66 |
|
|
|
85 |
|
|
|
126 |
|
|
|
205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME FROM
CONTINUING OPERATIONS BEFORE INCOME TAXES |
|
164 |
|
|
|
185 |
|
|
|
540 |
|
|
|
521 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income
taxes |
|
|
(25 |
) |
|
|
(1 |
) |
|
|
(99 |
) |
|
|
(63 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME FROM CONTINUING
OPERATIONS |
|
|
139 |
|
|
|
184 |
|
|
|
441 |
|
|
|
458 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME/(LOSS) FROM
DISCONTINUED OPERATIONS, NET OF TAX |
|
|
— |
|
|
|
8 |
|
|
|
— |
|
|
|
(27 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME |
|
139 |
|
|
|
192 |
|
|
|
441 |
|
|
|
431 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income attributable to
non-controlling interests |
|
|
(3 |
) |
|
|
(2 |
) |
|
|
(8 |
) |
|
|
(10 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME ATTRIBUTABLE TO
WTW |
|
$ |
136 |
|
|
$ |
190 |
|
|
$ |
433 |
|
|
$ |
421 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EARNINGS PER SHARE |
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations per share |
|
$ |
1.30 |
|
|
$ |
1.65 |
|
|
$ |
4.08 |
|
|
$ |
3.95 |
|
Income/(loss) from discontinued operations per share |
|
|
— |
|
|
|
0.07 |
|
|
|
— |
|
|
|
(0.24 |
) |
Basic earnings per share |
|
$ |
1.30 |
|
|
$ |
1.72 |
|
|
$ |
4.08 |
|
|
$ |
3.71 |
|
Diluted earnings per
share |
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations per share |
|
$ |
1.29 |
|
|
$ |
1.65 |
|
|
$ |
4.06 |
|
|
$ |
3.95 |
|
Income/(loss) from discontinued operations per share |
|
|
— |
|
|
|
0.07 |
|
|
|
— |
|
|
|
(0.24 |
) |
Diluted earnings per share |
|
$ |
1.29 |
|
|
$ |
1.72 |
|
|
$ |
4.06 |
|
|
$ |
3.71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average ordinary
shares, basic |
|
|
105 |
|
|
|
110 |
|
|
|
106 |
|
|
|
113 |
|
Weighted-average ordinary
shares, diluted |
|
|
105 |
|
|
|
111 |
|
|
|
107 |
|
|
|
114 |
|
WILLIS TOWERS WATSON PUBLIC LIMITED
COMPANYCondensed Consolidated Balance
Sheets(In millions of U.S. dollars, except share
data)(Unaudited) |
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2023 |
|
|
2022 |
|
ASSETS |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,247 |
|
|
$ |
1,262 |
|
Fiduciary assets |
|
|
8,039 |
|
|
|
11,772 |
|
Accounts receivable, net |
|
|
2,079 |
|
|
|
2,387 |
|
Prepaid and other current
assets |
|
|
469 |
|
|
|
414 |
|
Total current assets |
|
|
11,834 |
|
|
|
15,835 |
|
Fixed assets, net |
|
|
710 |
|
|
|
718 |
|
Goodwill |
|
|
10,143 |
|
|
|
10,173 |
|
Other intangible assets,
net |
|
|
2,064 |
|
|
|
2,273 |
|
Right-of-use assets |
|
|
533 |
|
|
|
586 |
|
Pension benefits assets |
|
|
908 |
|
|
|
827 |
|
Other non-current assets |
|
|
1,431 |
|
|
|
1,357 |
|
Total non-current assets |
|
|
15,789 |
|
|
|
15,934 |
|
TOTAL
ASSETS |
|
$ |
27,623 |
|
|
$ |
31,769 |
|
LIABILITIES AND
EQUITY |
|
|
|
|
|
|
Fiduciary liabilities |
|
$ |
8,039 |
|
|
$ |
11,772 |
|
Deferred revenue and accrued
expenses |
|
|
1,868 |
|
|
|
1,915 |
|
Current debt |
|
|
649 |
|
|
|
250 |
|
Current lease liabilities |
|
|
119 |
|
|
|
126 |
|
Other current liabilities |
|
|
630 |
|
|
|
716 |
|
Total current liabilities |
|
|
11,305 |
|
|
|
14,779 |
|
Long-term debt |
|
|
4,565 |
|
|
|
4,471 |
|
Liability for pension
benefits |
|
|
433 |
|
|
|
480 |
|
Deferred tax liabilities |
|
|
706 |
|
|
|
748 |
|
Provision for liabilities |
|
|
360 |
|
|
|
357 |
|
Long-term lease
liabilities |
|
|
569 |
|
|
|
620 |
|
Other non-current
liabilities |
|
|
200 |
|
|
|
221 |
|
Total non-current liabilities |
|
|
6,833 |
|
|
|
6,897 |
|
TOTAL
LIABILITIES |
|
|
18,138 |
|
|
|
21,676 |
|
COMMITMENTS AND
CONTINGENCIES |
|
|
|
|
|
|
EQUITY(i) |
|
|
|
|
|
|
Additional paid-in
capital |
|
|
10,903 |
|
|
|
10,876 |
|
Retained earnings |
|
|
1,127 |
|
|
|
1,764 |
|
Accumulated other
comprehensive loss, net of tax |
|
|
(2,620 |
) |
|
|
(2,621 |
) |
Treasury shares, at cost,
17,519 shares in 2022 |
|
|
— |
|
|
|
(3 |
) |
Total WTW
shareholders' equity |
|
|
9,410 |
|
|
|
10,016 |
|
Non-controlling interests |
|
|
75 |
|
|
|
77 |
|
Total
Equity |
|
|
9,485 |
|
|
|
10,093 |
|
TOTAL LIABILITIES AND
EQUITY |
|
$ |
27,623 |
|
|
$ |
31,769 |
|
______________ (i) Equity includes (a) Ordinary shares
$0.000304635 nominal value; Authorized 1,510,003,775; Issued
103,321,046 (2023) and 106,756,364 (2022); Outstanding 103,321,046
(2023) and 106,756,364 (2022) and (b) Preference shares, $0.000115
nominal value; Authorized 1,000,000,000 and Issued none in 2023 and
2022.
WILLIS TOWERS WATSON PUBLIC LIMITED
COMPANYCondensed Consolidated Statements of Cash
Flows(In millions of U.S. dollars)(Unaudited) |
|
|
|
Nine Months Ended September 30, |
|
|
|
2023 |
|
|
2022 |
|
CASH FLOWS FROM OPERATING
ACTIVITIES |
|
|
|
|
|
|
NET INCOME |
|
$ |
441 |
|
|
$ |
431 |
|
Adjustments to reconcile net
income to total net cash from operating activities: |
|
|
|
|
|
|
Depreciation |
|
|
184 |
|
|
|
191 |
|
Amortization |
|
|
203 |
|
|
|
239 |
|
Impairment |
|
|
— |
|
|
|
81 |
|
Non-cash restructuring
charges |
|
|
19 |
|
|
|
56 |
|
Non-cash lease expense |
|
|
83 |
|
|
|
94 |
|
Net periodic benefit of
defined benefit pension plans |
|
|
(20 |
) |
|
|
(113 |
) |
Provision for doubtful
receivables from clients |
|
|
8 |
|
|
|
13 |
|
Benefit from deferred income
taxes |
|
|
(58 |
) |
|
|
(92 |
) |
Share-based compensation |
|
|
87 |
|
|
|
71 |
|
Net (gain)/loss on disposal of
operations |
|
|
(44 |
) |
|
|
76 |
|
Non-cash foreign exchange
loss/(gain) |
|
|
1 |
|
|
|
(178 |
) |
Other, net |
|
|
21 |
|
|
|
(1 |
) |
Changes in operating assets
and liabilities, net of effects from purchase of subsidiaries: |
|
|
|
|
|
|
Accounts receivable |
|
|
261 |
|
|
|
270 |
|
Other assets |
|
|
(175 |
) |
|
|
(198 |
) |
Other liabilities |
|
|
(191 |
) |
|
|
(510 |
) |
Provisions |
|
|
3 |
|
|
|
7 |
|
Net cash from operating
activities |
|
|
823 |
|
|
|
437 |
|
|
|
|
|
|
|
|
CASH FLOWS USED IN INVESTING
ACTIVITIES |
|
|
|
|
|
|
Additions to fixed assets and
software for internal use |
|
|
(116 |
) |
|
|
(100 |
) |
Capitalized software
costs |
|
|
(66 |
) |
|
|
(50 |
) |
Acquisitions of operations,
net of cash acquired |
|
|
(6 |
) |
|
|
(80 |
) |
Proceeds from sale of
operations |
|
|
86 |
|
|
|
1 |
|
Cash and fiduciary funds
transferred in sale of operations |
|
|
(922 |
) |
|
|
(29 |
) |
(Purchase)/sale of
investments |
|
|
(6 |
) |
|
|
200 |
|
Net cash used in investing
activities |
|
|
(1,030 |
) |
|
|
(58 |
) |
|
|
|
|
|
|
|
CASH FLOWS USED IN FINANCING
ACTIVITIES |
|
|
|
|
|
|
Senior notes issued |
|
|
748 |
|
|
|
750 |
|
Debt issuance costs |
|
|
(7 |
) |
|
|
(5 |
) |
Repayments of debt |
|
|
(253 |
) |
|
|
(585 |
) |
Repurchase of shares |
|
|
(804 |
) |
|
|
(3,090 |
) |
Proceeds from issuance of
shares |
|
|
— |
|
|
|
7 |
|
Net (payments)/proceeds from
fiduciary funds held for clients |
|
|
(71 |
) |
|
|
157 |
|
Payments of deferred and
contingent consideration related to acquisitions |
|
|
(8 |
) |
|
|
(22 |
) |
Cash paid for employee taxes
on withholding shares |
|
|
(21 |
) |
|
|
(32 |
) |
Dividends paid |
|
|
(265 |
) |
|
|
(280 |
) |
Acquisitions of and dividends
paid to non-controlling interests |
|
|
(47 |
) |
|
|
(9 |
) |
Net cash used in financing
activities |
|
|
(728 |
) |
|
|
(3,109 |
) |
|
|
|
|
|
|
|
DECREASE IN CASH, CASH
EQUIVALENTS AND RESTRICTED CASH |
|
|
(935 |
) |
|
|
(2,730 |
) |
Effect of exchange rate
changes on cash, cash equivalents and restricted cash |
|
|
(54 |
) |
|
|
(290 |
) |
CASH, CASH EQUIVALENTS AND
RESTRICTED CASH, BEGINNING OF PERIOD(i) |
|
|
4,721 |
|
|
|
7,691 |
|
CASH, CASH EQUIVALENTS AND
RESTRICTED CASH, END OF PERIOD(i) |
|
$ |
3,732 |
|
|
$ |
4,671 |
|
______________(i) The amounts of cash, cash equivalents
and restricted cash, their respective classification on the
condensed consolidated balance sheets, as well as their respective
portions of the increase or decrease in cash, cash equivalents and
restricted cash for each of the periods presented have been
included in the Supplemental Disclosures of Cash Flow Information
section.
SUPPLEMENTAL DISCLOSURES OF CASH FLOW
INFORMATION
|
|
Nine Months Ended September 30, |
|
|
|
|
2023 |
|
|
|
2022 |
|
Supplemental disclosures of cash
flow information: |
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,247 |
|
|
$ |
1,496 |
|
Fiduciary funds (included in
fiduciary assets) |
|
|
2,485 |
|
|
|
3,170 |
|
Cash and cash equivalents and
fiduciary funds (included in current assets held for sale) |
|
|
— |
|
|
|
5 |
|
Total cash, cash equivalents and
restricted cash |
|
$ |
3,732 |
|
|
$ |
4,671 |
|
|
|
|
|
|
|
|
Increase/(decrease) in cash, cash
equivalents and other restricted cash |
|
$ |
5 |
|
|
$ |
(2,904 |
) |
(Decrease)/increase in fiduciary
funds |
|
|
(940 |
) |
|
|
174 |
|
Total(i) |
|
$ |
(935 |
) |
|
$ |
(2,730 |
) |
(i) Does not include the effect of exchange rate changes on
cash, cash equivalents and restricted cash.
Willis Towers Watson Pub... (NASDAQ:WTW)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Willis Towers Watson Pub... (NASDAQ:WTW)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024